bronchiectasis/gin diare

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 57 rezilta yo

[A case of hypogammaglobulinemia (IgA deficiency) with intestinal nodular lymphoid hyperplasia, bronchiectasis and recurrent diarrhea, with a special reference to the pathogenesis (author's transl)].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

X-linked Hyper-IgM Syndrome with Bronchiectasis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The X-linked hyper-immunoglobulin M syndrome (HIGM-1) is a rare genetic disorder characterized by elevated serum IgM levels and low to undetectable levels of serum IgG, IgA and IgE. These patients characteristically present with recurrent sinopulmonary infections and recurrent diarrhea. They also

[Diarrhea and weight loss in common variable immunodeficiency].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A 25-year-old male was hospitalized for diarrhea and weight loss. Since childhood he had experienced recurrent episodes of pneumonia and diarrhea. Physical and laboratory findings were compatible with malabsorption. On endoscopy, nodular lymphoid hyperplasia (NLH) of the small intestine was found.

Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Non-cystic fibrosis (non-CF) bronchiectasis is a condition characterized by an airway inflammatory response to bacterial pathogens. Frequent exacerbations have a major influence on the quality of life. Macrolide antibiotics have not only antibacterial but also immune-regulation effects. It is proved

Severe bronchiectasis in a patient with common variable immunodeficiency.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Bronchiectasis are common in Common Variable Immunodeficiency. These patients are prone to infection, leading to progressive lung destruction and accelerated FEV1 decline. METHODS 40 year-old man, with recurrent respiratory infections, autoimmunity and diarrhea since age 7. At 17 CVID was

Isolated immunoglobulin G4 subclass deficiency in a child with bronchiectasis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Immunoglobulin G4 subclass deficiency is the most common IgG subclass deficiency, followed by immunoglobulin G2 deficiency. However, IgG2 deficiency is the most common IgG subclass deficiency associated with recurrent infections. Immunoglobulin G4 subclass deficiency occurs in association with other

[Case of acute necrotizing esophagitis associated with AA amyloidosis secondary to bronchiectasis].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

An 82-year-old woman with a history of bronchiectasis for 20 years was admitted to our hospital with anorexia and diarrhea. Sigmoidoscopy showed multiple mucosal erythematous areas and erosions. Histologic examination with Congo red stain revealed massive amyloid deposition around the submucosal

[Amyloidosis secondary to bronchiectasis].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A 77-year-old woman was hospitalized repeatly due to frequent hemoptysis and production of bloodly sputum for several years. Bronchography in 1989 revealed bronchiectasis. She had complained of abdominal pain and diarrhea since 1991, and her urine was first positive for protein in 1992. She was

Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hypogammaglobulinemic sprue (HGS), which may predispose to infection, is uncommon. Twelve patients (all men; median age 29 years, 15-50) with HGS (4%) of 296 with chronic small bowel diarrhea and malabsorption syndrome (MAS) during a 10-year period were analyzed. Treatment of HGS was delayed due to

Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND The purpose of this study was to evaluate the clinical benefits and safety of the long-term use of macrolides in patients with non-cystic fibrosis (non-CF) bronchiectasis. METHODS Embase, Pubmed, the Cochrane Library and Web of Science databases were searched from inception up to March

Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND A systematic review and meta-analysis was conducted to evaluate the efficacy and safety of macrolide therapy in adults and children with bronchiectasis. METHODS We searched the PUBMED, EMBASE, CENTRAL databases to identify relevant studies. Two reviewers evaluated the studies and

Comparison of the serum concentration of zinc in patients with bronchiectasis and control group.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Bronchiectasis is an abnormal and permanent dilatation of bronchi. Infection plays a major role in causing and perpetuating bronchiectasis, as reducing the microbial load and attendant mediators are cornerstone of therapy. Zinc, as an integral micronutrient is involved in the immune

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Macrolide antibiotics have been shown beneficial in cystic fibrosis (CF) and diffuse panbronchiolitis, and earlier findings also suggest a benefit in non-CF bronchiectasis. OBJECTIVE To determine the efficacy of macrolide maintenance treatment for adults with non-CF

Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In this study the efficacy of bacampicillin and amoxicillin in treatment of bacterial lower respiratory tract infection were compared. Thirty-eight patients were treated with bacampicillin (800 mg twice a day), and 39 were treated with amoxicillin (500 mg three times a day). Conditions treated

[Clinical evaluation of cefpiramide in pediatrics].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cefpiramide (CPM) is a newly developed cephalosporin. Clinical studies on this drug were carried out and the results were as follows; Forty-three patients (purulent lymphadenitis 2, cellulitis 2, purulent otitis media 1, purulent tonsillitis 3, acute bronchitis 2, pneumonia 22, bronchiectasis 1,

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye